LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
A change to how initiatives that tackle malnutrition are funded is overdue after a paper reveals an additional €19bn ($23.25bn) is needed each year until 2030 to meet Sustainable Development Goals (SDGs).
Novartis will sell its stake in a consumer healthcare joint venture to partner GSK and plans to invest the $13bn into its core pharmaceutical businesses.
Chinese investment into Australian health firms, including supplement manufacturers, will continue to grow as the country's healthcare system matures and the population ages, analysts from KPMG are forecasting.
Multiple reports peg Nestlé as the front runner to buy Merck KGaA’s consumer health unit in a race that could result in a deal worth up to $5 billion (€4.1bn).
Global nutritional ingredients player DSM has acquired BioCare Copenhagen A/S in a deal that will see it expand its probiotic and gut health portfolio.
This year was a year of big M&A announcements. In case you missed it, we've compiled a short round-up of some major merges and acquisitions relevant to the dietary supplement industry:
From cognitive health to healthy ageing, and probiotics to immunity, 2017 saw suppliers targeting Asia-Pacific's key growth sectors with a raft of new products and insights.
After successfully completing a Series B financing, Microbiome Therapeutics is gearing up for the launch of a ‘microbiome modulator’ product designed to help balance the microbiome and support healthy metabolism.
Ingredient giant DowDuPont announced that it has completed the Health & Nutrition arm of FMC Corporation—other than its omega-3 business—to build on the former’s “sustainable, bio-based food ingredients” market share.
Israeli flavour and fine ingredients firm Frutarom are now the owners of nutritional ingredients specialists Enzymotec in a €144m ($168m) deal for the remaining 81% of company shares.
Pfizer announced that it is “reviewing strategic alternatives” for its Consumer Healthcare business, the parent company of many iconic over-the-counter (OTC) brands from dietary supplements to personal care.
